State Street’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
State Street's CLBT Position: Q2 2026 in Review
State Street increased its Cellebrite (CLBT) stake by 5.6% in Q2 2026, buying an estimated $752K and bringing the position to 1,077,950 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2483.
State Street first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $19.4M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- State Street held 1,077,950 shares of Cellebrite worth $15.7M as of Q2 2026.
- State Street bought 56,927 Cellebrite shares in Q2 2026, an estimated $752K.
- Cellebrite made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2483 holding.
- State Street first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
- State Street's Cellebrite position peaked at $19.4M in Q4 2025.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.